annual SGA:
$0.00-$18.95M(-100.00%)Summary
- As of today (August 19, 2025), ELVN annual SGA is $0.00, with the most recent change of -$18.95 million (-100.00%) on December 31, 2024.
- During the last 3 years, ELVN annual SGA has fallen by -$4.29 million (-100.00%).
- ELVN annual SGA is now -100.00% below its all-time high of $18.95 million, reached on December 31, 2023.
Performance
ELVN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$0.00-$6.80M(-100.00%)Summary
- As of today (August 19, 2025), ELVN quarterly SGA is $0.00, with the most recent change of -$6.80 million (-100.00%) on June 30, 2025.
- Over the past year, ELVN quarterly SGA has dropped by -$5.78 million (-100.00%).
- ELVN quarterly SGA is now -100.00% below its all-time high of $6.80 million, reached on March 31, 2025.
Performance
ELVN quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$1.03B-$100.22M(-10.74%)Summary
- As of today (August 19, 2025), ELVN TTM SGA is -$1.03 billion, with the most recent change of -$100.22 million (-10.74%) on June 30, 2025.
- Over the past year, ELVN TTM SGA has dropped by -$1.05 billion (-4959.51%).
- ELVN TTM SGA is now -1567.20% below its all-time high of -$61.97 million.
Performance
ELVN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ELVN Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | -100.0% | -4959.5% |
| 3 y3 years | -100.0% | -100.0% | -10000.0% |
| 5 y5 years | -100.0% | -100.0% | -10000.0% |
ELVN Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low | -109.6% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low | -670.2% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low | -1567.2% | at low |
ELVN Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $12.61M(-31.4%) |
| Mar 2025 | - | $6.80M(>+9900.0%) | $18.39M(+4.4%) |
| Dec 2024 | $0.00(-100.0%) | $0.00(-100.0%) | $17.60M(-21.5%) |
| Sep 2024 | - | $5.81M(+0.6%) | $22.43M(+5.5%) |
| Jun 2024 | - | $5.78M(-4.0%) | $21.26M(+4.0%) |
| Mar 2024 | - | $6.02M(+24.7%) | $20.43M(+7.8%) |
| Dec 2023 | $18.95M(+23.6%) | $4.82M(+3.9%) | $18.95M(+10.2%) |
| Sep 2023 | - | $4.64M(-6.2%) | $17.21M(+9.8%) |
| Jun 2023 | - | $4.95M(+9.1%) | $15.67M(+32.8%) |
| Mar 2023 | - | $4.54M(+47.5%) | $11.80M(+32.9%) |
| Dec 2022 | $15.33M | $3.08M(-0.9%) | $8.88M(-4.3%) |
| Sep 2022 | - | $3.10M(+187.8%) | $9.28M(-1.7%) |
| Jun 2022 | - | $1.08M(-33.4%) | $9.44M(-17.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.62M(-53.5%) | $11.45M(-11.9%) |
| Dec 2021 | $4.29M(-55.1%) | - | - |
| Dec 2021 | - | $3.48M(+6.6%) | $13.00M(+7.3%) |
| Sep 2021 | - | $3.26M(+5.4%) | $12.11M(+2.5%) |
| Jun 2021 | - | $3.10M(-2.2%) | $11.81M(+5.9%) |
| Mar 2021 | - | $3.17M(+22.2%) | $11.15M(+16.8%) |
| Dec 2020 | $9.54M(+86.9%) | $2.59M(-12.5%) | $9.54M(+37.3%) |
| Sep 2020 | - | $2.96M(+21.7%) | $6.95M(+21.3%) |
| Jun 2020 | - | $2.43M(+56.1%) | $5.73M(+73.7%) |
| Mar 2020 | - | $1.56M(-10.5%) | $3.30M(+89.5%) |
| Dec 2019 | $5.11M(+109.5%) | - | - |
| Sep 2019 | - | $1.74M | $1.74M |
| Dec 2018 | $2.44M(+147.0%) | - | - |
| Dec 2017 | $987.00K | - | - |
FAQ
- What is Enliven Therapeutics, Inc. annual SGA?
- What is the all time high annual SGA for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual SGA year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly SGA?
- What is the all time high quarterly SGA for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly SGA year-on-year change?
- What is Enliven Therapeutics, Inc. TTM SGA?
- What is the all time high TTM SGA for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. TTM SGA year-on-year change?
What is Enliven Therapeutics, Inc. annual SGA?
The current annual SGA of ELVN is $0.00
What is the all time high annual SGA for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual SGA is $18.95M
What is Enliven Therapeutics, Inc. annual SGA year-on-year change?
Over the past year, ELVN annual SGA has changed by -$18.95M (-100.00%)
What is Enliven Therapeutics, Inc. quarterly SGA?
The current quarterly SGA of ELVN is $0.00
What is the all time high quarterly SGA for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly SGA is $6.80M
What is Enliven Therapeutics, Inc. quarterly SGA year-on-year change?
Over the past year, ELVN quarterly SGA has changed by -$5.78M (-100.00%)
What is Enliven Therapeutics, Inc. TTM SGA?
The current TTM SGA of ELVN is -$1.03B
What is the all time high TTM SGA for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high TTM SGA is -$61.97M
What is Enliven Therapeutics, Inc. TTM SGA year-on-year change?
Over the past year, ELVN TTM SGA has changed by -$1.05B (-4959.51%)